The pharmacokinetic/pharmacodynamic paradigm for antimicrobial drugs in veterinary medicine: Recent advances and critical appraisal
- PMID: 33089523
- DOI: 10.1111/jvp.12917
The pharmacokinetic/pharmacodynamic paradigm for antimicrobial drugs in veterinary medicine: Recent advances and critical appraisal
Abstract
Pharmacokinetic/pharmacodynamic (PK/PD) modelling is the initial step in the semi-mechanistic approach for optimizing dosage regimens for systemically acting antimicrobial drugs (AMDs). Numerical values of PK/PD indices are used to predict dose and dosing interval on a rational basis followed by confirmation in clinical trials. The value of PK/PD indices lies in their universal applicability amongst animal species. Two PK/PD indices are routinely used in veterinary medicine, the ratio of the area under the curve of the free drug plasma concentration to the minimum inhibitory concentration (MIC) (fAUC/MIC) and the time that free plasma concentration exceeds the MIC over the dosing interval (fT > MIC). The basic concepts of PK/PD modelling of AMDs were established some 20 years ago. Earlier studies have been reviewed previously and are not reconsidered in this review. This review describes and provides a critical appraisal of more recent, advanced PK/PD approaches, with particular reference to their application in veterinary medicine. Also discussed are some hypotheses and new areas for future developments.First, a brief overview of PK/PD principles is presented as the basis for then reviewing more advanced mechanistic considerations on the precise nature of selected indices. Then, several new approaches to selecting PK/PD indices and establishing their numerical values are reviewed, including (a) the modelling of time-kill curves and (b) the use of population PK investigations. PK/PD indices can be used for dose determination, and they are required to establish clinical breakpoints for antimicrobial susceptibility testing. A particular consideration is given to the precise nature of MIC, because it is pivotal in establishing PK/PD indices, explaining that it is not a "pharmacodynamic parameter" in the usual sense of this term.
Keywords: PK/PD; antimicrobials; dosage regimen; veterinary medicine.
© 2020 The Authors. Journal of Veterinary Pharmacology and Therapeutics published by John Wiley & Sons Ltd.
Similar articles
-
Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization.Antimicrob Agents Chemother. 2011 Oct;55(10):4619-30. doi: 10.1128/AAC.00182-11. Epub 2011 Aug 1. Antimicrob Agents Chemother. 2011. PMID: 21807983 Free PMC article.
-
Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine.J Vet Pharmacol Ther. 2004 Dec;27(6):467-77. doi: 10.1111/j.1365-2885.2004.00613.x. J Vet Pharmacol Ther. 2004. PMID: 15601441 Review.
-
Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine.J Vet Pharmacol Ther. 2004 Dec;27(6):503-14. doi: 10.1111/j.1365-2885.2004.00603.x. J Vet Pharmacol Ther. 2004. PMID: 15601444 Review.
-
Pharmacokinetic-pharmacodynamic (PK-PD) modeling and the rational selection of dosage regimes for the prudent use of antimicrobial drugs.Vet Microbiol. 2014 Jul 16;171(3-4):480-6. doi: 10.1016/j.vetmic.2013.12.021. Epub 2014 Jan 9. Vet Microbiol. 2014. PMID: 24513278
-
Determination of the pharmacokinetic-pharmacodynamic cut-off values of marbofloxacin in horses to support the establishment of a clinical breakpoint for antimicrobial susceptibility testing.Equine Vet J. 2021 Sep;53(5):1047-1055. doi: 10.1111/evj.13385. Epub 2020 Dec 4. Equine Vet J. 2021. PMID: 33169427
Cited by
-
Effect of body size on the oral pharmacokinetics of oxytetracycline in rainbow trout (Oncorhynchus mykiss).PeerJ. 2024 Sep 11;12:e17973. doi: 10.7717/peerj.17973. eCollection 2024. PeerJ. 2024. PMID: 39282114 Free PMC article.
-
Systematic Review of the Pharmacological Evidence for the Selection of Antimicrobials in Bacterial Infections of the Central Nervous System in Dogs and Cats.Front Vet Sci. 2022 Jan 18;8:769588. doi: 10.3389/fvets.2021.769588. eCollection 2021. Front Vet Sci. 2022. PMID: 35118150 Free PMC article.
-
In Vitro Killing of Canine Urinary Tract Infection Pathogens by Ampicillin, Cephalexin, Marbofloxacin, Pradofloxacin, and Trimethoprim/Sulfamethoxazole.Microorganisms. 2021 Nov 2;9(11):2279. doi: 10.3390/microorganisms9112279. Microorganisms. 2021. PMID: 34835405 Free PMC article.
-
Pharmacodynamic Target Assessment and PK/PD Cutoff Determination for Gamithromycin Against Streptococcus suis in Piglets.Front Vet Sci. 2022 Jul 11;9:945632. doi: 10.3389/fvets.2022.945632. eCollection 2022. Front Vet Sci. 2022. PMID: 35898553 Free PMC article.
-
The Role of PK/PD Analysis in the Development and Evaluation of Antimicrobials.Pharmaceutics. 2021 Jun 3;13(6):833. doi: 10.3390/pharmaceutics13060833. Pharmaceutics. 2021. PMID: 34205113 Free PMC article. Review.
References
REFERENCES
-
- Ahmad, I., Huang, L., Hao, H., Sanders, P., & Yuan, Z. (2016). Application of PK/PD modeling in veterinary field: dose optimization and drug resistance prediction. BioMed Research International, 2016, 1-12. https://doi.org/10.1155/2016/5465678
-
- Aliabadi, F. S., Landoni, M. F., & Lees, P. (2003). Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of danofloxacin in sheep biological fluids. Antimicrobial Agents and Chemotherapy, 47(2), 626-635. https://doi.org/10.1128/AAC.47.2.626-635.2003
-
- Aliabadi, F. S., & Lees, P. (2001). Pharmacokinetics and pharmacodynamics of danofloxacin in serum and tissue fluids of goats following intravenous and intramuscular administration. American Journal of Veterinary Research, 62(12), 1979-1989. https://doi.org/10.2460/ajvr.2001.62.1979
-
- Aliabadi, F. S., & Lees, P. (2002). Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of marbofloxacin in calf serum, exudate and transudate. Journal of Veterinary Pharmacology and Therapeutics, 25(3), 161-174. https://doi.org/10.1046/j.1365-2885.2002.00399.x
-
- Ambrose, P. G. (2017). Antibacterial drug development program successes and failures: A pharmacometric explanation. Current Opinion in Pharmacology, 36, 1-7. https://doi.org/10.1016/j.coph.2017.06.002
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical